4-Bromo-2-fluorobenzoic acid → 6-[4-(4-Bromo-2-fluorobenzoyl)piperazin-1-yl]-5-methylnicotinonitrile
반응식
[Br:1][C:2]1[CH:10]=[CH:9][C:5]([C:6]([OH:8])=O)=[C:4]([F:11])[CH:3]=1.[CH3:12][C:13]1[C:14]([N:21]2[CH2:26][CH2:25][NH:24][CH2:23][CH2:22]2)=[N:15][CH:16]=[C:17]([CH:20]=1)[C:18]#[N:19]>>[Br:1][C:2]1[CH:10]=[CH:9][C:5]([C:6]([N:24]2[CH2:25][CH2:26][N:21]([C:14]3[C:13]([CH3:12])=[CH:20][C:17]([C:18]#[N:19])=[CH:16][N:15]=3)[CH2:22][CH2:23]2)=[O:8])=[C:4]([F:11])[CH:3]=1참가 물질
3
실험 절차
By reaction and treatment in the same manner as in Preparation Example 60 and using 4-bromo-2-fluorobenzoic acid (215 mg) and 5-methyl-6-piperazin-1-ylnicotinonitrile (202 mg), the title compound (433 mg) was obtained.
후처리
- customBy reaction and treatment in the same manner
- customas in Preparation Example 60
출처 및 근거
- ORD 기록
- ord-33503e40e11b4ff0abd8f98e39f3fa79
- 출처 데이터셋
- uspto-grants-2013_01
- 특허 번호
- US08354401B2
반응 노트
불러오는 중…